In a report issued on April 14, Whit Mayo from Leerink Partners reiterated a Buy rating on UnitedHealth (UNH – Research Report). The company's shares closed last Monday at $534.08, close to its 52-week high of $553.29. According to TipRanks.com, Mayo is a 4-star analyst with an average return of 8.9% and a 58.7% success rate. Mayo covers the Healthcare sector, focusing on stocks such as Airsculpt Technologies, Inc., Alignment Healthcare, and Privia Health Group. UnitedHealth has an analyst consensus of Strong Buy, with a price target consensus of $579.54, a 7.7% upside from current levels.
https://www.tipranks.com/news/blurbs/leerink-partners-keeps-their-buy-rating-on-unitedhealth-unh?utm_source=advfn.com&utm_medium=referral
UnitedHealth (NYSE:UNH)
Gráfica de Acción Histórica
De May 2022 a Jun 2022 Haga Click aquí para más Gráficas UnitedHealth.
UnitedHealth (NYSE:UNH)
Gráfica de Acción Histórica
De Jun 2021 a Jun 2022 Haga Click aquí para más Gráficas UnitedHealth.